OpenLB
Open Library of Bioscience
Advanced Search
BioMed research international
2022;2022 5419874.

Multidrug-Resistant Bacteria: Their Mechanism of Action and Prophylaxis.

Alok Bharadwaj, Amisha Rastogi, Swadha Pandey, Saurabh Gupta, Jagdip Singh Sohal
Author Information
  1. Alok Bharadwaj: Department of Biotechnology, GLA University, Mathura (U.P.)-281 406, India. ORCID
  2. Amisha Rastogi: Department of Biotechnology, GLA University, Mathura (U.P.)-281 406, India. ORCID
  3. Swadha Pandey: Department of Biotechnology, GLA University, Mathura (U.P.)-281 406, India. ORCID
  4. Saurabh Gupta: Department of Biotechnology, GLA University, Mathura (U.P.)-281 406, India. ORCID
  5. Jagdip Singh Sohal: Department of Biotechnology, GLA University, Mathura (U.P.)-281 406, India. ORCID
PMID: 36105930 DOI: 10.1155/2022/5419874

Abstract

In the present scenario, resistance to antibiotics is one of the crucial issues related to public health. Earlier, such resistance to antibiotics was limited to nosocomial infections, but it has now become a common phenomenon. Several factors, like extensive development, overexploitation of antibiotics, excessive application of broad-spectrum drugs, and a shortage of target-oriented antimicrobial drugs, could be attributed to this condition. Nowadays, there is a rise in the occurrence of these drug-resistant pathogens due to the availability of a small number of effective antimicrobial agents. It has been estimated that if new novel drugs are not discovered or formulated, there would be no effective antibiotic available to treat these deadly resistant pathogens by 2050. For this reason, we have to look for the formulation of some new novel drugs or other options or substitutes to treat such multidrug-resistant microorganisms (MDR). The current review focuses on the evolution of the most common multidrug-resistant bacteria and discusses how these bacteria escape the effects of targeted antibiotics and become multidrug resistant. In addition, we also discuss some alternative mechanisms to prevent their infection as well.

References

  1. Nanoscale. 2016 Mar 14;8(10):5750-4 [PMID: 26910517]
  2. Microbiol Mol Biol Rev. 2016 Feb 10;80(1):187-203 [PMID: 26864431]
  3. Molecules. 2015 Dec 28;21(1):E26 [PMID: 26729075]
  4. Adv Drug Deliv Rev. 2018 Mar 1;127:46-57 [PMID: 28939377]
  5. GMS Hyg Infect Control. 2017 Apr 10;12:Doc05 [PMID: 28451516]
  6. Front Microbiol. 2016 Oct 04;7:1580 [PMID: 27757108]
  7. Pediatr Infect Dis J. 2015 Jan;34(1):11-6 [PMID: 25093977]
  8. Antimicrob Agents Chemother. 2006 Feb;50(2):428-38 [PMID: 16436693]
  9. Int J Antimicrob Agents. 2013 Feb;41(2):130-6 [PMID: 23280442]
  10. J Nanobiotechnology. 2015 May 01;13:32 [PMID: 25929281]
  11. J Bacteriol. 1997 Apr;179(8):2557-66 [PMID: 9098053]
  12. Environ Microbiol. 2014 May;16(5):1297-309 [PMID: 25118351]
  13. Front Cell Infect Microbiol. 2017 Mar 13;7:55 [PMID: 28348979]
  14. Microb Genom. 2018 Jul;4(7): [PMID: 29975627]
  15. Ann Intern Med. 2002 Nov 19;137(10):791-7 [PMID: 12435215]
  16. Phytother Res. 2007 Apr;21(4):308-23 [PMID: 17199238]
  17. Future Microbiol. 2007 Jun;2(3):323-34 [PMID: 17661706]
  18. J Nanobiotechnology. 2012 May 06;10:19 [PMID: 22559747]
  19. Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9865-70 [PMID: 11481426]
  20. J Clin Diagn Res. 2014 Jun;8(6):DC01-4 [PMID: 25120976]
  21. Curr Top Med Chem. 2013;13(24):3079-100 [PMID: 24200360]
  22. Int J Med Microbiol. 2013 Aug;303(6-7):287-92 [PMID: 23499305]
  23. Gastroenterology. 2018 Nov;155(5):1372-1382.e17 [PMID: 29990487]
  24. Sci Technol Adv Mater. 2008 Sep 1;9(3):035004 [PMID: 27878001]
  25. Front Microbiol. 2017 Jan 16;7:2161 [PMID: 28138324]
  26. J Biomed Mater Res B Appl Biomater. 2009 Oct;91(1):470-80 [PMID: 19637369]
  27. Curr Protoc Microbiol. 2005 Oct;Appendix 3:Appendix 3C [PMID: 18770544]
  28. Cold Spring Harb Perspect Biol. 2010 May;2(5):a000414 [PMID: 20452953]
  29. ACS Nano. 2014 Jan 28;8(1):374-86 [PMID: 24341736]
  30. Environ Sci Technol. 2009 Nov 1;43(21):8423-9 [PMID: 19924979]
  31. Crit Care Med. 2001 Apr;29(4 Suppl):N82-6 [PMID: 11292880]
  32. Cold Spring Harb Perspect Med. 2016 Nov 1;6(11): [PMID: 27580748]
  33. Lipids Health Dis. 2019 Nov 14;18(1):196 [PMID: 31727081]
  34. Biomaterials. 2009 May;30(13):2552-8 [PMID: 19215980]
  35. Int J Infect Dis. 2013 Oct;17(10):e802-5 [PMID: 23672981]
  36. Lancet. 2010 May 1;375(9725):1557-68 [PMID: 20206987]
  37. Cleve Clin J Med. 2013 Apr;80(4):225-33 [PMID: 23547093]
  38. J Clin Invest. 2003 May;111(9):1265-73 [PMID: 12727914]
  39. Sci Rep. 2017 Sep 13;7(1):11479 [PMID: 28904369]
  40. Am J Respir Crit Care Med. 2005 Feb 15;171(4):388-416 [PMID: 15699079]
  41. Pediatr Infect Dis J. 2015 Sep;34(9):1023-5 [PMID: 26075812]
  42. Lancet Infect Dis. 2011 May;11(5):355-62 [PMID: 21478057]
  43. ScientificWorldJournal. 2013 May 28;2013:790580 [PMID: 23781160]
  44. Clin Infect Dis. 2006 Sep 1;43 Suppl 2:S43-8 [PMID: 16894514]
  45. J Infect Dis. 2010 Sep 15;202(6):924-34 [PMID: 20677941]
  46. Nat Prod Rep. 2016 Feb;33(2):317-47 [PMID: 26699732]
  47. Can J Infect Dis Med Microbiol. 2018 Jun 03;2018:3150965 [PMID: 29973964]
  48. Antimicrob Agents Chemother. 2005 Oct;49(10):4382-5 [PMID: 16189128]
  49. Infect Dis Clin North Am. 2016 Jun;30(2):377-390 [PMID: 27208764]
  50. Clin Microbiol Rev. 2015 Jul;28(3):603-61 [PMID: 26016486]
  51. Chem Soc Rev. 2014 Mar 7;43(5):1501-18 [PMID: 24292075]
  52. Clin Microbiol Rev. 2016 Jul;29(3):525-52 [PMID: 27076637]
  53. Curr Opin Microbiol. 2017 Jun;37:95-102 [PMID: 28623720]
  54. Chem Biol. 1999 Aug;6(8):493-505 [PMID: 10421756]
  55. Clin Microbiol Infect. 2009 Dec;15 Suppl 7:17-25 [PMID: 19951330]
  56. AAPS PharmSciTech. 2018 Jan;19(1):225-231 [PMID: 28681332]
  57. Infect Drug Resist. 2018 Nov 28;11:2497-2509 [PMID: 30555249]
  58. J Appl Microbiol. 2000 Jan;88(1):170-5 [PMID: 10735256]
  59. ACS Appl Mater Interfaces. 2015 Jan 28;7(3):2046-54 [PMID: 25584802]
  60. Trends Microbiol. 2009 Mar;17(3):130-8 [PMID: 19231190]
  61. Ann Intern Med. 2002 Jun 4;136(11):834-44 [PMID: 12044132]
  62. Chest. 2014 Oct;146(4):1038-1045 [PMID: 24901292]
  63. J Antimicrob Chemother. 2011 Mar;66(3):608-10 [PMID: 21217128]
  64. Chem Commun (Camb). 2014 Feb 9;50(11):1369-71 [PMID: 24346146]
  65. Dig Dis Sci. 2016 Aug;61(8):2373-2380 [PMID: 26923948]
  66. Iran J Basic Med Sci. 2016 Nov;19(11):1231-1237 [PMID: 27917280]
  67. BMC Res Notes. 2015 Aug 20;8:364 [PMID: 26289147]
  68. Infection. 2003 Jan;31(1):9-14 [PMID: 12590326]
  69. Clin Microbiol Infect. 2009 Mar;15(3):209-11 [PMID: 19335367]
  70. Biochemistry. 2014 Mar 18;53(10):1565-74 [PMID: 24576155]
  71. Ann Lab Med. 2015 Mar;35(2):205-11 [PMID: 25729722]
  72. Antimicrob Agents Chemother. 2009 Jun;53(6):2274-82 [PMID: 19273679]
  73. Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16964-9 [PMID: 20833818]
  74. Virulence. 2017 May 19;8(4):379-382 [PMID: 28402724]
  75. Cold Spring Harb Perspect Med. 2016 May 02;6(5): [PMID: 27091943]
  76. Curr Opin Struct Biol. 2010 Apr;20(2):234-40 [PMID: 20153164]
  77. Curr Protoc Microbiol. 2009 Nov;Appendix 3:Appendix 3C [PMID: 19885931]
  78. FEMS Microbiol Lett. 2012 Sep;334(2):87-94 [PMID: 22708802]
  79. Clin Microbiol Infect. 2009 Apr;15 Suppl 3:7-11 [PMID: 19366363]
  80. Sci Rep. 2015 Jun 05;5:11033 [PMID: 26046938]
  81. Nanomedicine. 2017 Oct;13(7):2199-2207 [PMID: 28614735]
  82. Lett Appl Microbiol. 1999 Aug;29(2):130-5 [PMID: 10499301]
  83. JAMA. 1993 Feb 3;269(5):598-602 [PMID: 8240468]
  84. Ann Intensive Care. 2015 Dec;5(1):61 [PMID: 26261001]
  85. PLoS One. 2014 Mar 18;9(3):e91713 [PMID: 24643200]
  86. Cold Spring Harb Perspect Med. 2016 Jun 01;6(6): [PMID: 27252397]
  87. JAMA. 2014 Oct 8;312(14):1447-55 [PMID: 25291580]
  88. Nat Rev Microbiol. 2009 Sep;7(9):629-41 [PMID: 19680247]
  89. Nat Chem Biol. 2016 Dec;12(12):1004-1006 [PMID: 27748750]
  90. Clin Microbiol Infect. 2010 Sep;16(9):1408-13 [PMID: 19845694]
  91. Curr Pharm Des. 2013;19(2):257-63 [PMID: 22934977]
  92. J Infect Dis. 2001 Oct 15;184(8):1029-34 [PMID: 11574918]
  93. GMS Hyg Infect Control. 2014 Sep 30;9(3):Doc23 [PMID: 25285267]
  94. Antimicrob Agents Chemother. 2006 Jul;50(7):2500-5 [PMID: 16801432]
  95. Nat Prod Rep. 2016 Feb;33(2):127-35 [PMID: 26175103]
  96. Interdiscip Perspect Infect Dis. 2012;2012:781679 [PMID: 22778729]
  97. Crit Care Clin. 2013 Oct;29(4):841-52 [PMID: 24094380]
  98. PLoS Negl Trop Dis. 2019 Aug 9;13(8):e0007624 [PMID: 31398198]
  99. Clin Microbiol Infect. 2006 Sep;12(9):826-36 [PMID: 16882287]
  100. Microb Drug Resist. 1999 Spring;5(1):45-52 [PMID: 10332721]
  101. Microbiol Mol Biol Rev. 2010 Sep;74(3):417-33 [PMID: 20805405]
  102. Semin Diagn Pathol. 2019 May;36(3):182-186 [PMID: 31056277]
  103. Am J Infect Control. 2013 Dec;41(12):1244-8 [PMID: 24011554]
  104. Ulster Med J. 2013 Sep;82(3):164-8 [PMID: 24505152]
  105. Antimicrob Agents Chemother. 1994 Sep;38(9):1980-3 [PMID: 7811006]
  106. ScientificWorldJournal. 2014;2014:410423 [PMID: 25025086]
  107. Emerg Infect Dis. 2002 Feb;8(2):160-6 [PMID: 11897067]
  108. N Engl J Med. 2008 Mar 20;358(12):1271-81 [PMID: 18354105]
  109. J Anaesthesiol Clin Pharmacol. 2017 Jul-Sep;33(3):300-305 [PMID: 29109626]
  110. Trends Mol Med. 2012 May;18(5):263-72 [PMID: 22480775]
  111. J Biomed Mater Res A. 2014 Jun;102(6):1823-8 [PMID: 23784968]
  112. Clin Infect Dis. 2011 May;52 Suppl 5:S397-428 [PMID: 21474585]
  113. FEMS Immunol Med Microbiol. 2012 Jun;65(1):5-22 [PMID: 22309135]
  114. Antimicrob Agents Chemother. 2014 Dec;58(12):7240-9 [PMID: 25246402]
  115. Biointerphases. 2016 Mar 08;11(1):011003 [PMID: 26746161]
  116. BMC Complement Altern Med. 2006 Nov 30;6:39 [PMID: 17134518]
  117. J Infect Public Health. 2014 May-Jun;7(3):224-32 [PMID: 24631369]
  118. Int J Antimicrob Agents. 2001;18 Suppl 1:S25-8 [PMID: 11574191]
  119. J Infect. 2013 May;66(5):401-14 [PMID: 23142195]
  120. Adv Drug Deliv Rev. 2005 Jul 29;57(10):1451-70 [PMID: 15950313]
  121. mBio. 2016 Sep 27;7(5): [PMID: 27677793]
  122. Front Microbiol. 2017 Jan 04;7:2094 [PMID: 28101081]
  123. ACS Appl Mater Interfaces. 2014 Aug 27;6(16):14369-76 [PMID: 25046207]
  124. Lancet Infect Dis. 2002 Sep;2(9):530-8 [PMID: 12206969]
  125. BMC Genomics. 2011 Oct 17;12:512 [PMID: 22004526]
  126. PLoS One. 2012;7(5):e37152 [PMID: 22629360]
  127. Int J Med Microbiol. 2002 Jun;292(1):27-35 [PMID: 12139425]
  128. Nat Chem Biol. 2016 Apr;12(4):233-9 [PMID: 26829473]
  129. Science. 1999 May 21;284(5418):1318-22 [PMID: 10334980]
  130. Int J Antimicrob Agents. 2009 Jun;33(6):587-90 [PMID: 19195845]
  131. Antimicrob Agents Chemother. 2014;58(4):2126-34 [PMID: 24468775]
  132. J Bacteriol. 2013 Jun;195(11):2585-94 [PMID: 23543715]
  133. Bioresour Technol. 2008 Jul;99(10):4239-46 [PMID: 17920880]
  134. Sci Prog. 2002;85(Pt 1):57-72 [PMID: 11969119]
  135. Curr Top Microbiol Immunol. 2017;404:1-44 [PMID: 26919863]
  136. Molecules. 2020 Jun 23;25(12): [PMID: 32586045]
  137. Clin Infect Dis. 2015 Sep 15;61 Suppl 2:S48-57 [PMID: 26316558]
  138. BMC Res Notes. 2018 Aug 31;11(1):629 [PMID: 30170613]
  139. J Glob Antimicrob Resist. 2019 Mar;16:36-47 [PMID: 30149193]
  140. Genes Dis. 2019 Apr 17;6(2):109-119 [PMID: 31194018]
  141. Clin Infect Dis. 2014 Jan;58(2):225-32 [PMID: 24099919]
  142. Expert Rev Anti Infect Ther. 2014 Feb;12(2):239-48 [PMID: 24392717]
  143. Am J Med. 1999 May 3;106(5A):19S-25S; discussion 48S-52S [PMID: 10348060]
  144. Eur J Clin Microbiol Infect Dis. 2007 Dec;26(12):857-68 [PMID: 17701432]
  145. Clin Microbiol Infect. 2014 Dec;20(12):O1117-20 [PMID: 24931918]
  146. Can Fam Physician. 1998 Sep;44:1881-8 [PMID: 9789668]
  147. Antimicrob Agents Chemother. 2013 Aug;57(8):3969-75 [PMID: 23733476]

MeSH Term

Anti-Bacterial Agents
Bacteria
Cross Infection
Drug Resistance, Multiple, Bacterial
Humans

Chemicals

Anti-Bacterial Agents
Journal Article Review
Article has an altmetric score of 4

Word Cloud

Created with Highcharts 10.0.0antibioticsdrugsresistancebecomecommonantimicrobialpathogenseffectivenewnoveltreatresistantmultidrug-resistantbacteriapresentscenarioonecrucialissuesrelatedpublichealthEarlierlimitednosocomialinfectionsnowphenomenonSeveralfactorslikeextensivedevelopmentoverexploitationexcessiveapplicationbroad-spectrumshortagetarget-orientedattributedconditionNowadaysriseoccurrencedrug-resistantdueavailabilitysmallnumberagentsestimateddiscoveredformulatedantibioticavailabledeadly2050reasonlookformulationoptionssubstitutesmicroorganismsMDRcurrentreviewfocusesevolutiondiscussesescapeeffectstargetedmultidrugadditionalsodiscussalternativemechanismspreventinfectionwellMultidrug-ResistantBacteria:MechanismActionProphylaxis

Similar Articles

Cited By